Celularity

Youtube Subscribe

Open: 0.21 Close: 0.23 Change: 0.02

You don't have read the whole internet to decide whether to invest in Celularity Company Inc. Use an AI.

Are looking for the most relevant information about Celularity? Investor spend a lot of time searching for information to make investment decisions in Celularity. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Celularity are: Celularity, price, Inc, share, outstanding, M, CELU, and the most common words in the summary are: celularity, best, inc, credit, stock, market, price, . One of the sentences in the summary was: Celularity Inc Registered Shs -A- Stock started trading at the price of $0.21 on …

Concept Map

Semantic Network

Stock Summary

Celularity Inc. develops placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. The company's lead therapeutic programs include CYCART-19, an allogeney CAR-T cell.

Today's Summary

Celularity Inc. (CELU) has 190.95 million shares outstanding. The average price target for Celularity is $1.75, which is 665.53% higher than the current price. Celularity announces receipt of Nasdaq notice regarding late form 10-Q filing. Celularity Inc Registered Shs -A- Stock started trading at the price of $0.21 on Monday morning 11/27/2023. Compared to the closing price on Friday 11/24/20th on NAS, this is a drop of 0.80%. There are 190.95 M shares outstanding, which values the company at $40.74 M.

Today's News

Celularity Inc. (CELU) has 190.95 million shares outstanding. The average price target for Celularity is $1.75, which is 665.53% higher than the current price. Celularity announces receipt of Nasdaq notice regarding late form 10-Q filing. Celularity Inc Registered Shs -A- Stock started trading at the price of $0.21 on Monday morning 11/27/2023. Compared to the closing price on Friday 11/24/20th on NAS, this is a drop of 0.80%. There are 190.95 M shares outstanding, which values the company at $40.74 M.

Stock Profile

"Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, an allogeneic CAR-T cell for the treatment of non-Hodkin's lymphoma (NHL) and mantle cell lymphoma (MCL); CYNK-001, an allogeneic unmodified natural killer cell that is in Phase I/II clinical trial for the treatment of acute myeloid leukemia (AML); and APPL-001, a genetically modified placental-derived mesenchymal-like adherent stromal cell for the treatment of Crohn's disease. It is also developing CYCART-201 for the treatment of NHL and MCL, and human epidermal growth factor receptor 2 positive cancers; CYNK-301, a next generation chimeric antigen receptor-natural killer (CAR-NK) for treating relapse refractory AML; CYNK-302, a CAR-NK to treat non-small cell lung cancer; and pExo-001, a human postpartum placenta derived exosome product for the treatment of osteoarthritis. It also produces, sells, and licenses products that are used in surgical and wound care markets, such as Biovance, Biovance 3L, Interfyl, and Centaflex; and collects and stores stem cells from umbilical cords and placentas under the LifebankUSA brand. The company has licensing agreement with Sorrento Therapeutics, Inc. for the development and commercialization of licensed CD19 CAR-T products. The company was founded in 1998 and is based in Florham Park, New Jersey."

Keywords

How much time have you spent trying to decide whether investing in Celularity? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Celularity are: Celularity, price, Inc, share, outstanding, M, CELU, and the most common words in the summary are: celularity, best, inc, credit, stock, market, price, . One of the sentences in the summary was: Celularity Inc Registered Shs -A- Stock started trading at the price of $0.21 on Monday morning 11/27/2023. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #celularity #best #inc #credit #stock #market #price.

Read more →

Youtube Subscribe

---